A detailed history of Raymond James & Associates transactions in Ishares Global Healthcare ETF stock. As of the latest transaction made, Raymond James & Associates holds 66,445 shares of IXJ stock, worth $6.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
66,445
Previous 64,222 3.46%
Holding current value
$6.12 Million
Previous $5.96 Million 9.39%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$91.63 - $101.25 $203,693 - $225,078
2,223 Added 3.46%
66,445 $6.52 Million
Q2 2024

Jul 19, 2024

BUY
$87.41 - $94.12 $617,726 - $665,146
7,067 Added 12.36%
64,222 $5.96 Million
Q1 2024

Apr 22, 2024

BUY
$87.55 - $93.2 $569,337 - $606,079
6,503 Added 12.84%
57,155 $5.32 Million
Q4 2023

Jan 16, 2024

BUY
$78.24 - $86.72 $219,854 - $243,683
2,810 Added 5.87%
50,652 $4.39 Million
Q3 2023

Oct 24, 2023

BUY
$82.27 - $86.96 $12,505 - $13,217
152 Added 0.32%
47,842 $3.94 Million
Q2 2023

Jul 25, 2023

SELL
$82.57 - $87.62 $54,661 - $58,004
-662 Reduced 1.37%
47,690 $4.05 Million
Q1 2023

Apr 14, 2023

SELL
$79.07 - $85.5 $3,479 - $3,762
-44 Reduced 0.09%
48,352 $4.03 Million
Q4 2022

Feb 08, 2023

SELL
$75.71 - $87.41 $21,653 - $24,999
-286 Reduced 0.59%
48,396 $4.11 Million
Q3 2022

Oct 25, 2022

BUY
$74.91 - $84.22 $16,929 - $19,033
226 Added 0.47%
48,682 $3.67 Million
Q2 2022

Aug 12, 2022

SELL
$75.99 - $91.39 $70,822 - $85,175
-932 Reduced 1.89%
48,456 $3.93 Million
Q1 2022

May 11, 2022

BUY
$80.95 - $89.4 $27,603 - $30,485
341 Added 0.7%
49,388 $4.33 Million
Q4 2021

Feb 08, 2022

BUY
$82.63 - $90.54 $244,089 - $267,455
2,954 Added 6.41%
49,047 $4.43 Million
Q3 2021

Nov 02, 2021

BUY
$83.44 - $89.6 $362,379 - $389,132
4,343 Added 10.4%
46,093 $3.86 Million
Q2 2021

Aug 11, 2021

BUY
$76.9 - $83.42 $371,965 - $403,502
4,837 Added 13.1%
41,750 $3.47 Million
Q1 2021

May 14, 2021

SELL
$73.43 - $79.62 $69,611 - $75,479
-948 Reduced 2.5%
36,913 $2.85 Million
Q4 2020

Feb 12, 2021

SELL
$68.25 - $76.45 $45,795 - $51,297
-671 Reduced 1.74%
37,861 $2.89 Million
Q3 2020

Nov 04, 2020

SELL
$69.15 - $73.99 $1.64 Million - $1.76 Million
-23,773 Reduced 38.16%
38,532 $2.77 Million
Q2 2020

Jul 28, 2020

BUY
$58.71 - $70.81 $101,920 - $122,926
1,736 Added 2.87%
62,305 $4.29 Million
Q1 2020

Apr 21, 2020

SELL
$51.5 - $70.89 $60,358 - $83,083
-1,172 Reduced 1.9%
60,569 $3.69 Million
Q4 2019

Feb 12, 2020

SELL
$59.37 - $69.08 $68,275 - $79,442
-1,150 Reduced 1.83%
61,741 $4.25 Million
Q3 2019

Nov 07, 2019

SELL
$59.43 - $62.78 $354,202 - $374,168
-5,960 Reduced 8.66%
62,891 $3.84 Million
Q2 2019

Aug 06, 2019

SELL
$57.44 - $62.09 $2.56 Million - $2.77 Million
-44,595 Reduced 39.31%
68,851 $4.25 Million
Q1 2019

May 06, 2019

BUY
$55.2 - $61.69 $127,291 - $142,257
2,306 Added 2.07%
113,446 $6.93 Million
Q4 2018

Feb 11, 2019

BUY
$53.92 - $63.41 $29,494 - $34,685
547 Added 0.49%
111,140 $6.3 Million
Q3 2018

Nov 14, 2018

BUY
$56.43 - $63.01 $79,509 - $88,781
1,409 Added 1.29%
110,593 $6.97 Million
Q2 2018

Aug 14, 2018

BUY
$54.51 - $57.91 $1.92 Million - $2.04 Million
35,300 Added 47.78%
109,184 $6.16 Million
Q1 2018

May 14, 2018

BUY
$54.36 - $61.53 $1.55 Million - $1.76 Million
28,581 Added 63.09%
73,884 $8.23 Million
Q4 2017

Feb 14, 2018

BUY
$54.92 - $57.4 $1.13 Million - $1.18 Million
20,563 Added 83.12%
45,303 $5.1 Million
Q3 2017

Nov 13, 2017

BUY
$55.75 - $56.23 $79,834 - $80,521
1,432 Added 6.14%
24,740 $2.78 Million
Q2 2017

Aug 14, 2017

BUY
N/A
23,308
23,308 $2.55 Million

Others Institutions Holding IXJ

About ISHARES GLOBAL HEALTHCARE ETF


  • Ticker IXJ
  • Sector ETFs
  • Industry Closed-End Fund - Equity
More about IXJ
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.